Buprenorphine Hydrochloride
Product Images NDC 53217-246

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Buprenorphine Hydrochloride (NDC 53217-246). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aidarex Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Buprenorphine HCl Sublingual 1)

Chemical structure diagram of buprenorphine hydrochloride depicting its molecular arrangement including rings, hydroxyl, methoxy, and cyclopropyl groups, along with the hydrochloride salt component.*

FDA Label Image

Figure (Buprenorphine HCl Sublingual 2)

An instructional black-and-white line drawing showing a person opening their mouth and lifting their tongue while placing a round tablet or film under the tongue with a finger, illustrating sublingual administration.*

FDA Label Image

Package Label (Buprenorphine HCl Sublingual 3)

Packaging label for buprenorphine hydrochloride sublingual tablets, 8 mg strength, containing 30 tablets. The label shows the product is generic for Subutex with NDC 53217-0246-30, manufactured by Ethypharma S.A. France, and packaged by Aidarex Pharmaceuticals LLC. The label also includes caution information and instructions to take the medication at specified intervals.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.